D-0942-2023 Class II Terminated
FDA drug recall D-0942-2023 was initiated by Kramer Laboratories, Inc. on Jun 23, 2023 and is designated Class II. Reason for recall: CGMP Deviations: use of non-food grade lubricant in mixing vessel. The recall status is terminated (terminated Mar 12, 2024).
Recall details
- Product Type
- Drugs
- Report Date
- Aug 2, 2023
- Initiation Date
- Jun 23, 2023
- Termination Date
- Mar 12, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Safe Tussin DM Cough + Chest Congestion (Dextromethorphan HBr/ Cough Suppressant Guaifenesin/Expectorant), packaged in 4.0 FL OZ(118mL), 2020 Kramer Laboratories, Inc. Bridgewater, NJ 08807
Reason for recall
CGMP Deviations: use of non-food grade lubricant in mixing vessel.
Distribution pattern
nationwide within the United States
Code information
Lot #: 8753, 8753A, Exp. Date 10/2023 Lot #: 8659 Exp. Date 8/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0942-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026